Prognostic value of serum lactate dehydrogenase in symptomatic multiple myeloma.

被引：0
|
作者：
Patel, Krina K. [1 ]
Orlowski, Robert Z. [1 ]
Weber, Donna M. [1 ]
Wang, Michael [1 ]
Thomas, Sheeba K. [1 ]
Shah, Jatin J. [1 ]
Turturro, Francesco [1 ]
Alexanian, Raymond [1 ]
Delasalle, Kay [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8093
引用
收藏
页数：1
相关论文
共 50 条
  • [1] High Serum Lactate Dehydrogenase (LDH) Is An Important Prognostic Factor in the Era of Novel Agents and Adds to the Prognostic Value of the International Staging System (ISS) in Patients with Multiple Myeloma.
    Dimopoulos, Meletios A.
    Roussou, Maria
    Pouli, Anastasia
    Katodritou, Eirini
    Symeonidis, Argiris
    Michalis, Eurydiki
    Grigoraki, Vassiliki
    Anagnostopoulos, Nikolaos
    Zomas, Athanasios
    Delimpasi, Sosana
    Parharidou, Agapi
    Kartasis, Zafiris
    Viniou, Nora-Athina
    Gika, Dimitra
    Terpos, Evangelos
    Economopoulos, Theofanis
    Zervas, Konstantinos
    BLOOD, 2009, 114 (22) : 722 - 722
  • [2] Prognostic value of markers of bone turnover in multiple myeloma.
    Terpos, E
    Szydlo, R
    Hatziharissi, E
    de la Fuente, J
    Viniou, N
    Meletis, J
    Yataganas, X
    Apperley, JF
    Goldman, JM
    Rahemtulla, A
    BLOOD, 2002, 100 (11) : 372B - 373B
  • [3] The Prognostic Role of Lactate Dehydrogenase at First Relapse of Multiple Myeloma
    Lee, Holly
    Jimenez-Zepeda, Victor H.
    ACTA HAEMATOLOGICA, 2020, 143 (06) : 516 - 517
  • [4] Prognostic value of lactate dehydrogenase in Chinese patients with newly diagnosed transplant eligible multiple myeloma
    Huang, Beihui
    Lu, Jin
    Wang, Xiaotao
    Xiao, Yang
    Zhao, Ying
    Huang, Hongming
    Liu, Junru
    Chen, Meilan
    Gu, Jingli
    Yuan, Shiwen
    Zheng, Dong
    Li, Yonghua
    Huang, Xiaojun
    Li, Juan
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1740 - 1742
  • [5] Prognostic value of the serum marker of bone resorption sCTX in addition to other biological prognostic factors in multiple myeloma.
    Leleu, X
    Duche, A
    Duhamel, A
    Yakoub-Agha, I
    Delannoy, V
    Brazier, M
    Faucompret, JL
    Bauters, F
    Facon, T
    BLOOD, 2001, 98 (11) : 300B - 300B
  • [6] Prognostic value of preoperative serum lactate dehydrogenase in thymic carcinoma
    Yuan, Zu-Yang
    Gao, Shu-Geng
    Mu, Ju-Wei
    Xue, Qi
    Mao, You-Sheng
    Wang, Da-Li
    Zhao, Jun
    Gao, Yu-Shun
    Huang, Jin-Feng
    He, Jie
    JOURNAL OF THORACIC DISEASE, 2016, 8 (09) : 2464 - 2472
  • [7] Clinical relevance and prognostic value of minimal residual disease in multiple myeloma.
    Terragna, C
    Martinelli, G
    Rossi, M
    Bonifazi, F
    Soverini, S
    Amabile, M
    Giannini, B
    Ottaviani, E
    Buonamici, S
    Zamagni, E
    Cellini, C
    Tosi, P
    Tura, S
    Cavo, M
    Baccarani, M
    BLOOD, 2002, 100 (11) : 599A - 599A
  • [8] Prognostic value of whole body FDG/PET scanning in multiple myeloma.
    Durie, BG
    Waxman, AD
    D'Agnolo, A
    Williams, CM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 31P - 31P
  • [9] Prognostic value of whole body FDG/PET scanning in multiple myeloma.
    Durie, BGM
    Waxman, A
    D'Agnolo, A
    BLOOD, 2000, 96 (11) : 836A - 837A
  • [10] Prognostic features of asymptomatic multiple myeloma.
    Weber, DM
    Dimopoulos, MA
    Moulopoulos, LA
    Delasalle, KB
    Smith, TL
    Alexanian, R
    BLOOD, 1996, 88 (10) : 1548 - 1548
12345